Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction to Prevent First Major Cardiovascular Events (OCEAN(a)-PreEvent, NCT07136012)

Educational Partners and Supporters

AstraZeneca has provided a sponsorship grant towards this independent programme.